115
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Determination of albumin adducts of 4,4′-methylenediphenyl diisocyanate in workers of a 4,4′-methylenedianiline factory

, , &
Pages 731-738 | Received 11 Jan 2016, Accepted 24 Mar 2016, Published online: 04 May 2016

References

  • Argikar UA. (2012). Unusual glucuronides Drug Metab Dispos 40:1239–51.
  • Baur X. (1990). New aspects of isocyanate asthma. Lung 168:606–13.
  • Baur X, Marek W, Ammon J, et al. (1994). Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health 66:141–52.
  • Bernstein JA. (1996). Overview of diisocyanate occupational asthma. Toxicology 111:181–9.
  • Blaszkewicz M, Dannappel D, Thier R, Lewalter J. (2004). N-acetyltransferase 2 (genotyping). Anal Hazard Subst Biol Mater 9:135–63.
  • Bolognesi C, Baur X, Marczynski B, et al. (2001). Carcinogenic risk of toluene diisocyanate and 4,4'-methylenediphenyl diisocyanate: epidemiological and experimental evidence. Crit Rev Toxicol 31:737–72.
  • Bunnelle WH. (2011). Reagents for stereoselective preparation of N-carbamyl β-D-glucuronides J Org Chem 76:5429–32.
  • Delclos KB, Kadlubar FF. (1997). Carcinogenic aromatic amines and amides. In: Sipes IG, McQueen CA, Gandolfi AJ, eds. Comprehensive toxicology. Oxford, UK: Elsevier Science Ltd., 141–70.
  • Grant DM, Tang BK, Kalow W. (1984). A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol 17:459–64.
  • Gries W, Leng G. (2013). Analytical determination of specific 4,4'-Methylene diphenyl diisocyanate hemoglobin adducts in human blood. Anal Bioanal Chem 405:7205–13.
  • Henderson RF, Bechtold WE, Bond JA, Sun JD. (1989). The use of biological markers in toxicology. Crit Rev Toxicol 20:65–82.
  • Henriks-Eckerman ML, Makela EA, Laitinen J, et al. (2015). Role of dermal exposure in systemic intake of methylenediphenyl diisocyanate (MDI) among construction and boat building workers. Toxicol Lett 232:595–600.
  • Hoymann HG, Buschmann J, Heinrich U. (1995). Untersuchungen zur chronischen Toxizität/Kanzerogenität von 4,4’-Methylendiphenyl-diisocyanat (MDI). Hannover, Germany: Fraunhofer-Institut für Toxikologie und Aerosolforschung.
  • ICH. (1996). International Conference on harmonization of technical requirements for the registration of pharmaceuticals for human use, validation of analytical procedures: text and methodology. ICH-Q2B. Geneva: ICH.
  • Karol MH. (1986). Respiratory effects of inhaled isocyanates. Crit Rev Toxicol 16:349–79.
  • Kazanis S, McClelland RA. (1992). Electrophilic intermediate in the reaction of glutathione and nitroso arenes. J Am Chem Soc 114:3052–9.
  • Kumar A, Dongari N, Sabbioni G. (2009). New isocyanate-specific albumin adducts of 4,4'-methylenediphenyl diisocyanate (MDI) in rats. Chem Res Toxicol 22:1975–83.
  • Lewalter J, Korallus U. (1985). Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring. Int Arch Occup Environ Health 56:179–96.
  • Lewalter J, Miksche W. (1991). Empfehlungen zur arbeitsmedizinischen Prävention expositions- und dispositionsbedingter Arbeitsstoff-Beanspruchungen. Verh Dt Ges Arbeitsmed 31:135–9.
  • Liljelind I, Norberg C, Egelrud L, et al. (2010). Dermal and inhalation exposure to methylene bisphenyl isocyanate (MDI) in iron foundry workers. Ann Occup Hyg 54:31–40.
  • Mapp CE, Saetta M, Maestrelli P, et al. (1994). Low molecular weight pollutants and asthma: pathogenetic mechanisms and genetic factors. Eur Respir J 7:1559–63.
  • Munn SJ, Allanou R, Aschberger K, et al. (2005). EUR 22104 EN European Union Risk Assessment Report: methylenediphenyl diisocyanate (MDI). Luxembourg: European Commission, Office for Official Publications of the European Communities.
  • Pearson PG, Slatter JG, Rashed MS, et al. (1991). Carbamoylation of peptides and proteins in vitro by S-(N-methylcarbamoyl)glutathione and S-(N-methylcarbamoyl)cysteine, two electrophilic S-linked conjugates of methyl isocyanate. Chem Res Toxicol 4:436–44.
  • Raulf-Heimsoth M, Baur X. (1998). Pathomechanisms and pathophysiology of isocyanate-induced diseases–summary of present knowledge. Am J Ind Med 34:137–43.
  • Redlich CA, Karol MH. (2002). Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2:213–24.
  • Ringe D, Turesky RJ, Skipper PL, Tannenbaum SR. (1988). Structure of the single stable hemoglobin adduct formed by 4-aminobiphenyl in vivo. Chem Res Toxicol 1:22–4.
  • Sabbioni G. (1990). Chemical and physical properties of the major serum albumin adduct of aflatoxin B1 and their implications for the quantification in biological samples. Chem-Biol Interact 75:1–15.
  • Sabbioni G, Dongari N, Kumar A. (2010). Determination of a new biomarker in subjects exposed to 4,4′-methylenediphenyl diisocyanate. Biomarkers 15:508–15.
  • Sabbioni G, Hartley R, Henschler D, et al. (2000). Isocyanate-specific hemoglobin adduct in rats exposed to 4, 4'-methylenediphenyl diisocyanate. Chem Res Toxicol 13:82–9.
  • Sabbioni G, Jones CR. (2002). Biomonitoring of arylamines and nitroarenes. Biomarkers 7:347–421.
  • Sabbioni G, Lamb JH, Farmer PB, Sepai O. (1997). Reactions of 4-methylphenyl isocyanate with amino acids. Biomarkers 2:223–32.
  • Sabbioni G, Schutze D. (1998). Hemoglobin binding of bicyclic aromatic amines. Chem Res Toxicol 11:471–83.
  • Sabbioni G, Wesp H, Lewalter J, Rumler R. (2007). Determination of isocyanate biomarkers in construction site workers. Biomarkers 12:468–83.
  • Sabbioni G, Dongari N, Schneider S, Kumar A. (2012). Synthetic approaches to obtain amino acid adducts of 4,4'-methylenediphenyl diisocyanate. Chem Res Toxicol 25:2704–14.
  • Scholl PF, Groopman JD. (2008). Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence. Cancer Epidemiol Biomarkers Prev 17:1436–9.
  • Schutze D, Sagelsdorff P, Sepai O, Sabbioni G. (1996). Synthesis and quantification of DNA adducts of 4,4'-methylenedianiline. Chem Res Toxicol 9:1103–12.
  • Schutze D, Sepai O, Lewalter J, et al. (1995). Biomonitoring of workers exposed to 4,4'-methylenedianiline or 4,4'-methylenediphenyl diisocyanate. Carcinogenesis 16:573–82.
  • Sepai O, Schutze D, Heinrich U, et al. (1995). Hemoglobin adducts and urine metabolites of 4,4'-methylenedianiline after 4,4'-methylenediphenyl diisocyanate exposure of rats. Chem-Biol Interact 97:185–98.
  • Shrivastava A, Gupta V. (2011). Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron Young Sci 2:21–5.
  • Skipper PL, Tannenbaum SR. (1990). Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11:507–18.
  • Slatter JG, Rashed MS, Pearson PG, et al. (1991). Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities. Chem Res Toxicol 4:157–61.
  • Tornqvist M, Fred C, Haglund J, et al. (2002). Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B Analyt Technol Biomed Life Sci 778:279–308.
  • Vock EH, Hoymann HG, Heinrich U, Lutz WK. (1996). 32P-postlabeling of a DNA adduct derived from 4,4'-methylenedianiline, in the olfactory epithelium of rats exposed by inhalation to 4,4'-methylenediphenyl diisocyanate. Carcinogenesis 17:1069–73.
  • Vock EH, Lutz WK. (1997). Distribution and DNA adduct formation of radiolabeled methylenediphenyl-4,4'-diisocyanate (MDI) in the rat after topical treatment. Toxicol Lett 92:93–100.
  • Wisnewski AV, Liu J, Redlich CA. (2013). Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure. Chem Biol Interact 205:38–45.
  • Wisnewski AV, Srivastava R, Herick C, et al. (2000). Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med 162:2330–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.